PARIS (Reuters) – France will achieve solid growth faster than expected, Prime Minister Manuel Valls said on Friday, as data showed households more optimistic than they have been in four and a half years.
Speaking two days ahead of local elections where his unpopular Socialist party expects a severe defeat, Valls said improving economic data meant growth could be strong enough to bring unemployment down this year.
PARIS, March 23 (Reuters) – Shares in Sika leapt on
Monday after the Swiss chemicals firm said it had won a key
court ruling in its battle to fend off a back-door takeover by
The French building materials group said the ruling by the
Court of Zug did not change the fundamentals of the case, but
the family it is buying a disputed stake from acknowledged that
the decision effectively strips away its voting rights at a
forthcoming shareholders’ meeting on April 14.
PARIS (Reuters) – Former president Nicolas Sarkozy’s conservative UMP party and their allies led in the first round of French local elections, exit polls showed on Sunday, denying Marine Le Pen’s far-right National Front (FN) first place.
If confirmed, the result would be a setback for Le Pen, who had hoped her anti-immigrant, anti-euro party would emerge top in the first round, boosting her ambitions to win presidential elections set for 2017.
PARIS, March 5 (Reuters) – Numericable-SFR is
confident it can deliver the 1 billion euros of cost savings
promised by cable operator Numericable by 2017 from its takeover
of No.2 French mobile telecoms group SFR, finance head Thierry
Lemaitre said on Thursday.
Lemaitre also told reporters on a conference call that the
new company made a net loss for 2014 of 175 million euros ($193
million) against a profit of 65 million a year earlier due to
interest costs for the debt it raised for the takeover and
including a one-month contribution from SFR.
PARIS, Feb 20 (Reuters) – Sanofi’s new boss
Olivier Brandicourt could earn up to 4.2 million euros ($4.8
million) a year at the drugs group and pocket an extra 4
million euros within 12 months as a one-off golden handshake.
The pay of the former medical doctor, due to take up his new
role from April, was revealed in a statement from the company on
Friday, a day after the 59-year-old Bayer executive
was named as replacement for Chris Viehbacher, who was sacked in
PARIS, Feb 19 (Reuters) – French drugmaker Sanofi
on Thursday named Olivier Brandicourt, a Paris-educated doctor
and head of Bayer AG’s healthcare arm, as its chief
Brandicourt had been widely tipped to become Sanofi’s new
boss, a position that opened when Chris Viehbacher was suddenly
sacked last year.
PARIS, Feb 19 (Reuters) – Olivier Brandicourt, the
Paris-educated doctor and head of Bayer AG’s
healthcare arm who is widely tipped as the new boss of Sanofi
, comes with the right scientific and cultural pedigree
but faces some daunting corporate challenges.
The 59-year-old Frenchman who researched tropical and
infectious diseases before joining the corporate drugs world has
been seen as a likely candidate to head the French drugs firm
ever since the board suddenly sacked Chris Viehbacher last year.
PARIS, Feb 12 (Reuters) – Power switch and socket maker
Legrand warned that challenging prospects in Russia
and difficult conditions in mature European markets would drag
on revenue growth in 2015 as it delivered yearly earnings that
Shares in the French company, which had risen earlier this
month to a record 49.02 euros, were down 3 percent at 45.685
euros in early trade, compared with a 0.2 percent drop in the
French blue-chip CAC 40 index.
PARIS, Feb 5 (Reuters) – French drugs firm Sanofi
said on Thursday it would be in a position to name a new chief
executive in the coming weeks as it delivered 1.5 percent
quarterly earnings per share growth thanks to the weak euro.
“The announcement will be before the end of the first
quarter,” said Chairman Serge Weinberg, who has been acting CEO
since Chris Viehbacher was fired at the end of October for poor
execution of strategy and lack of communication with the board.
PARIS, Jan 30 (Reuters) – Barring a last-minute
breakthrough, drugs firm Sanofi’s Chairman Serge
Weinberg may have to acknowledge in his results presentation
next week that the hunt for a new chief executive is not going
At least three potential candidates in a narrow field have
turned their back on the job heading France’s largest company.